SSX7 Antikörper (N-Term)

Produktnummer ABIN1881839

Es sind 2+ Publikationen für dieses Produkt verfügbar. Der Kaninchen Polyklonal anti-SSX7 Antikörper wird verwendet zum Nachweis von SSX7 in Proben von Human. Er wurde validiert für WB.

Kurzübersicht für SSX7 Antikörper (N-Term) (ABIN1881839)

Target: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SSX7 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Klon: RB41797

Produktdetails anti-SSX7 Antikörper

Bindungsspezifität: AA 1-30, N-Term

Aufreinigung: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This SSX7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human SSX7.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Haltbarkeit: 6 months

Referenzen für anti-SSX7 Antikörper (ABIN1881839)

Güre, Wei, Old, Chen: "The SSX gene family: characterization of 9 complete genes." in: International journal of cancer. Journal international du cancer, Vol. 101, Issue 5, pp. 448-53, (2002) (PubMed).

Chen, Chen, Lee, Huang, Yang, Tsai, Chen, Sheu: "Expressions of cancer-testis antigens in human hepatocellular carcinomas." in: Cancer letters, Vol. 164, Issue 2, pp. 189-95, (2001) (PubMed).

Details zu SSX7

Target: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Andere Bezeichnung: SSX7

Hintergrund: The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation.

Molekulargewicht: 21591

NCBI Accession: NP_775494

UniProt: Q7RTT5